SCHEMBL2390141

SCHEMBL2390141

Cc1c(C(=O)Nc2cc(C(=O)OCN(C(=O)c3nnn(Cc4ccc(Cl)c(Cl)c4)c3C)c3cc(CO)ccc3F)ccc2F)nnn1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.38
POLB P06746 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 8/20 0.36
TSHR P16473 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
TP53 P04637 2/20 0.34
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 3/20 0.33
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33
LMNA P02545 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR4 P22455 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2367582 0.83 KCNH2 (0.48) KCNH2POLBALDH1A1MAPTTSHR
SCHEMBL2367082 0.83 KCNH2 (0.47) KCNH2POLBALDH1A1MAPTTSHR
SCHEMBL15329329 0.80 KCNH2 (0.46) KCNH2POLBALDH1A1MAPTTSHR
SCHEMBL2367664 0.76 MAPT (0.48) POLBALDH1A1MAPTTSHRMEN1
SCHEMBL2367249 0.76 MAPT (0.47) POLBALDH1A1MAPTTSHRMEN1
SCHEMBL2367584 0.74 MAPT (0.54) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL2367928 0.73 MAPT (0.55) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL2368338 0.73 MAPT (0.55) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL15329816 0.73 PTGDR2 (0.48) POLBMAPTTSHRPTGDR2SMN1; SMN2
SCHEMBL2367566 0.72 MAPK1 (0.51) MAPTTSHRMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2368887-A1 1, 2, 3-triazole derivatives for use as stearoyl-COA desaturase inhibitors Glaxosmithkline LLC (US) 2011-09-28 EP disclosed